Novonix Limited
NVNXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $210 | $239 | $477 | $1,083 |
| - Cash | $43 | $79 | $74 | $143 |
| + Debt | $70 | $68 | $40 | $41 |
| Enterprise Value | $238 | $228 | $443 | $982 |
| Revenue | $6 | $8 | $4 | $6 |
| % Growth | -27.3% | 118.1% | -39.5% | – |
| Gross Profit | $4 | $5 | -$21 | $4 |
| % Margin | 69.8% | 65% | -558.6% | 71.7% |
| EBITDA | -$67 | -$39 | -$33 | -$46 |
| % Margin | -1,137.8% | -482.5% | -901% | -756.9% |
| Net Income | -$75 | -$46 | -$38 | -$52 |
| % Margin | -1,278% | -574.2% | -1,031.1% | -850% |
| EPS Diluted | -0.15 | -0.095 | -0.078 | -0.11 |
| % Growth | -58.1% | -21.7% | 29.1% | – |
| Operating Cash Flow | -$40 | -$36 | -$13 | -$29 |
| Capital Expenditures | -$30 | -$19 | -$17 | -$84 |
| Free Cash Flow | -$70 | -$55 | -$30 | -$113 |